AMAG Pharmaceuticals competitors

Zippia score 4.9

AMAG Pharmaceuticals main competitors are Novartis, Eli Lilly and Company, and Gilead Sciences.

Competitor Summary. See how AMAG Pharmaceuticals compares to its main competitors:

Novartis has the most employees (110,000).
Employees at Novartis earn more than most of the competitors, with an average yearly salary of $112,479.
The oldest company is Pfizer, founded in 1849.

Work at AMAG Pharmaceuticals?

Share your experience

AMAG Pharmaceuticals vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
AMAG Pharmaceuticals	1981	4.9	Waltham, MA	2	$418.0M	552
Maxygen	1997	4.0	San Mateo, CA	1	$30.0M	8
Regeneron	1988	4.9	Tarrytown, NY	7	$14.2B	9,123
PDL BioPharma	1986	4.2	Incline Village, NV	1	$30.7M	75
Seagen	1997	4.7	Bothell, WA	3	$2.0B	900
Gilead Sciences	1987	4.5	Foster City, CA	9	$28.8B	11,800
Human Genome Sciences	1992	4.9	Rockville, MD	1	$131.0M	1,000
Sanofi Genzyme	1981	4.8	Cambridge, MA	1	$4.6B	12,000
Pfizer	1849	4.5	New York, NY	18	$63.6B	78,500
Novartis	1996	4.9	East Hanover, NJ	16	$51.7B	110,000
KV Pharmaceutical	1942	4.1	Chesterfield, MO	1	$91.0M	7,500
Novella	1998	4.2	Morrisville, NC	1	$9.2M	3,000
Eli Lilly and Company	1876	4.6	Indianapolis, IN	4	$45.0B	33,625
Merial Limited	1981	4.8	Duluth, GA	1	$2.7B	6,900

Rate how well AMAG Pharmaceuticals differentiates itself from its competitors.

AMAG Pharmaceuticals salaries vs competitors

Among AMAG Pharmaceuticals competitors, employees at Novartis earn the most with an average yearly salary of $112,479.

Compare AMAG Pharmaceuticals salaries vs competitors

Company	Average salary	Hourly salary	Salary score
AMAG Pharmaceuticals	$73,642	$35.40	-
Maxygen	$71,411	$34.33	-
Regeneron	$85,589	$41.15	-
PDL BioPharma	$48,962	$23.54	-
Seagen	$85,008	$40.87	-
Gilead Sciences	$99,828	$47.99	-

Compare AMAG Pharmaceuticals job title salaries vs competitors

Company	Highest salary	Hourly salary
AMAG Pharmaceuticals	$67,747	$32.57
Merial Limited	$117,126	$56.31
Novartis	$112,785	$54.22
Eli Lilly and Company	$110,661	$53.20
Regeneron	$98,870	$47.53
Pfizer	$95,232	$45.78
Sanofi Genzyme	$94,952	$45.65
Gilead Sciences	$94,165	$45.27
Novella	$80,938	$38.91
KV Pharmaceutical	$73,386	$35.28
Human Genome Sciences	$69,750	$33.53
Maxygen	$63,382	$30.47
Seagen	$59,728	$28.72
PDL BioPharma	$57,611	$27.70

Do you work at AMAG Pharmaceuticals?

Does AMAG Pharmaceuticals effectively differentiate itself from competitors?

AMAG Pharmaceuticals jobs

AMAG Pharmaceuticals demographics vs competitors

Compare gender at AMAG Pharmaceuticals vs competitors

Job title	Male	Female
PDL BioPharma	46%	54%
Eli Lilly and Company	53%	47%
Regeneron	54%	46%
Pfizer	55%	45%
Gilead Sciences	56%	44%
AMAG Pharmaceuticals	-	-

Male

Female

100%

75%

50%

25%

Eli Lilly and Company

PDL BioPharma

25%

50%

75%

100%

Compare race at AMAG Pharmaceuticals vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
Eli Lilly and Company	59%	15%	9%	13%	4%	9.8
Gilead Sciences	44%	20%	8%	23%	6%	9.8
PDL BioPharma	54%	15%	7%	19%	4%	9.3
Pfizer	55%	18%	10%	13%	4%	9.8
Regeneron	54%	15%	10%	17%	4%	9.8
Sanofi Genzyme	61%	14%	7%	14%	4%	9.8

AMAG Pharmaceuticals and similar companies CEOs

CEOBio

David A. Ricks

Eli Lilly and Company

I'm the chairman and CEO of Eli Lilly and Company, after holding management roles in the U.S., Canada and China, as well as running Lilly’s largest business unit. Before I joined Lilly in 1996, I worked as an account rep at IBM. I'm on the board of Adobe, and I'm chairman of the board of the Pharmaceutical Research and Manufacturers of America (PhRMA). I also serve on the board of the Central Indiana Corporate Partnership. I'm a member of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) CEO Steering Committee, The Business Council, Business Roundtable and the National Council for Expanding American Innovation (NCEAI). I serve on the Riley Children’s Foundation’s board of governors. I am a digital media spokesperson for Lilly and discuss topics related to our company, our business and the health care environment. We operate in a highly regulated environment, and only designated employees can discuss our products or pipeline. If you need information about our products or have questions or concerns, please visit these resources: https://e.lilly/guidelines

Daniel O’Day

Gilead Sciences

Christopher Stone

PDL BioPharma

Dr. Albert Bourla

Pfizer

Albert Bourla (Greek: Άλμπερτ Μπουρλά, born) is a Greek veterinarian and the chairman and chief executive officer of Pfizer, an American pharmaceutical company. He joined the company in 1993 and has held several executive roles across Pfizer's divisions. Prior to becoming chief executive officer, Bourla served as chief operating officer.

Roger D. Dansey

Seagen

Paul Hudson

Sanofi Genzyme

Andrew Witty

Human Genome Sciences

Carsten Hellmann

Merial Limited

Vasant Narasimhan

Novartis

Vasant "Vas" Narasimhan is an American physician and the chief executive officer of Novartis (since 2018).

Richard Staub

Novella